Investments
312Portfolio Exits
64Funds
1About Alexandria Venture Investments
Alexandria Venture Investments, the strategic investment arm of Alexandria Center® at Kendall Square, has been supporting innovation and entrepreneurship by investing important and significant capital in the broad and diverse science and technology sectors. Alexandria is uniquely positioned to fund science and advanced technology companies based on experience and in-depth understanding of the science and technology industries, its long-term relationships with top-tier science and technology investors and research institutions, and its world-class international network.
Alexandria Venture Investments Headquarter Location
Pasadena, California,
United States
Expert Collections containing Alexandria Venture Investments
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Alexandria Venture Investments in 1 Expert Collection, including Game Changers 2018.
Game Changers 2018
20 items
Research containing Alexandria Venture Investments
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Alexandria Venture Investments in 1 CB Insights research brief, most recently on Aug 5, 2021.
Aug 5, 2021
Here Are The Most Active Healthcare InvestorsLatest Alexandria Venture Investments News
Apr 27, 2022
Pheast Therapeutics , a Palo Alto, CA-based company developing checkpoint therapies to fight cancer, raised $76M in Series A funding. The round was led by Catalio Capital Management and ARCH Venture Partners with participation from Alexandria Venture Investments and Risk and Reward. The company intend sto use the funds to expand its management, scientific, and administrative teams, as well as towards R&D to advance its pipeline of innate immune checkpoint inhibitors towards the clinic. Led by scientific experts Dr. Amira Barkal, MD, PhD, Dr. Irving Weissman, MD, Dr. Ravi Majeti, MD, PhD, and Dr. Roy Maute, PhD., Pheast is a pre-clinical stage immuno-oncology company focused on targeting cancer immune evasion pathways to activate the innate immune system in the fight against cancer. Its primary program targets the surface protein CD24, a “don’t eat me” signal commandeered by many cancers, including ovarian and breast cancer, in order to avoid detection and clearance by intra-tumoral macrophages. Pheast is also leveraging its proprietary discovery platform to enable the development of additional novel tumor-specific cancer immunotherapies. FinSMEs 27/04/2022
Alexandria Venture Investments Investments
312 Investments
Alexandria Venture Investments has made 312 investments. Their latest investment was in DEM BioPharma as part of their Series A on June 6, 2022.
Alexandria Venture Investments Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/23/2022 | Series A | DEM BioPharma | $70M | Yes | 3 | |
5/25/2022 | Seed VC | Pleno | $15M | Yes | 8 | |
5/17/2022 | Series B | Remix Therapeutics | $70M | No | 5 | |
5/10/2022 | Series B | |||||
5/9/2022 | Series B |
Date | 6/23/2022 | 5/25/2022 | 5/17/2022 | 5/10/2022 | 5/9/2022 |
---|---|---|---|---|---|
Round | Series A | Seed VC | Series B | Series B | Series B |
Company | DEM BioPharma | Pleno | Remix Therapeutics | ||
Amount | $70M | $15M | $70M | ||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 3 | 8 | 5 |
Alexandria Venture Investments Portfolio Exits
64 Portfolio Exits
Alexandria Venture Investments has 64 portfolio exits. Their latest portfolio exit was Tara Biosystems on April 05, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
4/5/2022 | Acquired | 3 | |||
2/3/2022 | Reverse Merger | 3 | |||
1/7/2022 | IPO | Public | 7 | ||
Date | 4/5/2022 | 2/3/2022 | 1/7/2022 | ||
---|---|---|---|---|---|
Exit | Acquired | Reverse Merger | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 3 | 3 | 7 |
Alexandria Venture Investments Fund History
1 Fund History
Alexandria Venture Investments has 1 fund, including Alexandria Seed Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
Alexandria Seed Fund | 3 |
Closing Date | |
---|---|
Fund | Alexandria Seed Fund |
Fund Type | |
Status | |
Amount | |
Sources | 3 |
Alexandria Venture Investments Team
1 Team Member
Alexandria Venture Investments has 1 team member, including current Senior Vice President, Jenna Foger.
Name | Work History | Title | Status |
---|---|---|---|
Jenna Foger | Senior Vice President | Current |
Name | Jenna Foger |
---|---|
Work History | |
Title | Senior Vice President |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.